["{\n\"step_by_step_thinking\": \"The relevant documents describe the use of GnRH agonists in various medical conditions. Continuous GnRH therapy is used for suppression of pituitary-ovarian axis function to induce ovulation and synchronize oocyte maturation. According to [Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH agonists], the suppressive effect occurred by 14 days in 77% of the patients, and never required more than 28 days. This suggests that continuous GnRH therapy is used for a prolonged period of time to achieve desired effects. Based on this information, we can conclude that GnRH analogs are not typically used for prostate cancer treatment.\",\n\"answer_choice\": \"B\""]